Join Annette Bowyer as She Explores Heparin-Induced Thrombocytopenia!
Sysmex Europe Haemostasis shared on LinkedIn:
”We are delighted to launch Season 2 of our haemostasis webinar series “Haemostasis and Beyond. Meet the Expert”!
Our first session will focus on an important topic:
Heparin-induced thrombocytopenia (HIT) – a severe complication in patients treated with heparins, including unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). HIT can result in serious thromboembolic events, often associated with considerable morbidity and mortality.
Join Annette Bowyer as she explores:
- What HIT is and how it develops
- Current approaches to diagnosis and management
- The essential role of the HISCL HIT IgG assay kit in supporting patient care
Save the date: 16.10.2025, 11:00 CEST
Link.
Do not miss the opening session of Season 2 – expand your knowledge, meet the experts, and stay at the forefront of haemostasis diagnostics.”

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia